Procare Health partners with Biovaxys to develop cancer vaccines

Barcelona-based biotech Procare Health has partnered with Canadian BioVaxys to jointly develop and commercialize vaccines for ovarian cancer, cervical cancer and human papillomavirus. In a statement, both companies have specified that this collaboration will be channeled through a patented platform of haptenized viral antigens to stimulate a personalized immune response.